[Internal therapy of peripheral arterial blood circulation disorders].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000368:Aged; D000804:Angiotensin II / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use*; D002908:Chronic Disease; D003097:Collateral Circulation / Q000187:drug effects; D003374:Coumarins / Q000627:therapeutic use*; D004837:Epinephrine / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005081:Exercise Therapy; D005263:Femoral Artery; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008729:Methoxamine / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use*; D011150:Popliteal Artery; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D014652:Vascular Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000900:Anti-Bacterial Agents; D003374:Coumarins; D004876:Ergot Alkaloids; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D013565:Sympatholytics; D013566:Sympathomimetics; D000804:Angiotensin II; D012110:Reserpine; D000255:Adenosine Triphosphate; D011433:Propranolol; D010208:Papaverine; D008729:Methoxamine; D002746:Chlorpromazine; D004837:Epinephrine
Internistische Behandlung peripherer arterieller Durchblutungsstörungen.